Abstract

ObjectivesCancer patients are considered a very vulnerable group of the population to SARS-CoV-2 infection and the development of more severe COVID-19 symptoms, which may be due to a systemic immunosuppressive...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call